Phase II study of combination therapy with Irinotecan and S-1 in patients with progressive colorectal cancer after FOLFOX regimen
收藏NIAID Data Ecosystem2026-03-06 收录
官方服务：
资源简介：
Interventions: Irinotecan+S-1, repeated every 3 weeks. Primary outcome(s): RR Study Design: Single arm Non-randomized
创建时间：
2007-08-15
